Evidence map›Paper›PMID 25285951›Full record

ArticlePloS one2014

Pro-inflammatory cytokines reduce the proliferation of NG2 cells and increase shedding of NG2 in vivo and in vitro.

Malin Wennström, Shorena Janelidze, Cecilie Bay-Richter, Lennart Minthon, Lena Brundin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. NG2 Glia and Cellular Crosstalk in Health and Disease: Focus on Spinal Cord Injury.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Extracellular Matrix in Neural Plasticity and Regeneration.Cellular and molecular neurobiology · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.Progress in neuro-psychopharmacology & biological psychiatry · 2018
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Malin WennströmLund University, Department of Clinical Sciences, Clinical Memory Research Unit, Wallenberg Laboratory, Malmö, Sweden.
Shorena JanelidzeLund University, Department of Clinical Sciences, Clinical Memory Research Unit, Wallenberg Laboratory, Malmö, Sweden.
Cecilie Bay-RichterAarhus University, Department of Clinical Medicine, Translational Neuropsychiatry Unit, Risskov, Denmark.
Lennart MinthonLund University, Department of Clinical Sciences, Clinical Memory Research Unit, Wallenberg Laboratory, Malmö, Sweden.
Lena BrundinMichigan State University, College of Human Medicine, Department of Psychiatry and Behavioral Medicine, Grand Rapids, Michigan, United States of America; Van Andel Research Institute, Laboratory of Behavioral Medicine, Grand Rapids, Michigan, United States of America.
Lund University · SEAarhus University · DKMichigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuron glial 2 (NG2) cells become strongly activated in injured brain areas. The activation is characterized by increased proliferation as well as increased expression and shedding of the proteoglycan NG2 expressed on their cell surface. It is currently not known how these cells respond to low-grade neuroinflammation provoked by systemic inflammation. To investigate this, we analyzed NG2 cell proliferation as well as soluble NG2 (sNG2) in cerebrospinal fluid (CSF) from rats treated with an acute intraperitoneal (i.p) injection of lipopolysaccharides (LPS) or saline and sacrificed after 2 or 24 hours. The systemically induced neuroinflammation was confirmed as elevated levels of cytokines, including interleukin (IL)-6 and IL-1β, and MHCII expressing microglia were found 24 h after LPS treatment. At this time point NG2 cell proliferation was significantly decreased in both amygdala and hippocampus and sNG2 levels in CSF were increased twofold. We also exposed human NG2 cells in culture to IL-6 and IL-1β for 24 h and found, in line with our in vivo study, a direct impact of these cytokines reducing cell proliferation and increasing shedding of NG2. We conclude that LPS induced systemic inflammation significantly affects NG2 cell proliferation and shedding and that these two events at least in in part are mediated by IL-6 and IL-1β.

Indexed as

AnimalsBrainCell ProliferationCytokinesHumansInflammationLipopolysaccharidesMaleMicrogliaNeurogliaOligodendrogliaRatsRats, WistarSolubilityCytokinesLipopolysaccharides

Identifiers

PMID25285951
PMCPMC4186831
OpenAlexW2070896403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.